|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 298 IDR | +1.36% |
|
+3.47% | -14.37% |
| 04-29 | PT Suparma Tbk Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 04-01 | PT Suparma Tbk Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
PT Suparma Tbk reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was IDR 1,924,882.71 million compared to IDR 1,539,111.45 million a year ago. Net income was IDR 188,172.17 million compared to IDR 83,637.18 million a year ago.
Basic earnings per share from continuing operations was IDR 70.7965.
| 1st Jan change | Capi. | |
|---|---|---|
| -14.37% | 57.54M | |
| +29.83% | 6.11B | |
| +41.36% | 2.8B | |
| +13.70% | 1.6B | |
| -7.06% | 1.57B | |
| -14.09% | 1.2B | |
| +24.67% | 1.08B | |
| -1.93% | 1.02B | |
| +37.57% | 838M | |
| -9.26% | 829M |
PT SUPARMA TBK 